Variants in STAT4 Associated With Cure of Chronic HBV Infection in HBeAg-positive Patients Treated With Pegylated Interferon-alpha-Reference-Cited by-同舟云学术

Variants in STAT4 Associated With Cure of Chronic HBV Infection in HBeAg-positive Patients Treated With Pegylated Interferon-alpha

Published:2020-01 Issue:1 Volume:18 Page:196-204.e8
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Chen Haitao^ORCID,Sun Jian,Zhou Bin,Xie Qing,Liang Xier,Fan Rong,Conran Carly^ORCID,Xu Jianfeng,Ji Yuan^ORCID,Zhang Xinxin,Sun Li,Jia Jidong,Wang Guiqiang,Hou Jinlin,Jiang De-Ke

Funder

National Natural Science Foundation of China

National Science and Technology

Local Innovative and Research Teams Project

Innovative Research Team Project of Guangxi Province

Nanfang Hospital

Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference33 articles.

1. Hepatitis B in China;Liu;Lancet,2007

2. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

3. Hepatocellular carcinoma and hepatitis B virus;Chan;Semin Liver Dis,2006

4. EASL 2017 Clinical practice guidelines on the management of hepatitis B virus infection;J Hepatol,2017

5. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma;Jiang;Nat Genet,2013

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CXCR7 genetic variant predicts treatment response of pegylated-interferon α in HBeAg-positive chronic hepatitis B patients;Antiviral Research;2024-11

2. A genetic variant of CXCR4 predicts pegylated interferon-alpha treatment response in HBeAg-positive chronic hepatitis B patients;Journal of Clinical Microbiology;2024-02-14

3. Higher BST2 Expression Promotes the Anti‐HBV Effect of IFN‐α and BST2 Genetic Variant Predicts PegIFNα Treatment Response of HBeAg‐Positive Chronic Hepatitis B Patients;Clinical Pharmacology & Therapeutics;2023-12-13

4. Assessment of STAT4 Variants and Risk of Hepatocellular Carcinoma in Latin Americans and Europeans;Cancers;2023-09-12

5. CXCL13 variant predicts pegylated‐interferon α treatment response in HBeAg‐positive chronic hepatitis B patients;Journal of Medical Virology;2023-07